SCHEMBL8868628

SCHEMBL8868628

O=C(CCc1ccccc1)NCCc1cccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 5/20 0.50
HIF1A Q16665 4/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868901 0.92 P4HTM (0.51) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL9139301 0.92 P4HTM (0.61) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8870568 0.91 P4HTM (0.47) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8869704 0.91 P4HTM (0.45) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8869181 0.91 P4HTM (0.54) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8869839 0.89 P4HTM (0.46) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8869014 0.89 P4HTM (0.54) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL8867695 0.89 P4HTM (0.48) P4HTMHIF1ARAB9ANPC1SMN1; SMN2
SCHEMBL9139292 0.89 P4HTM (0.49) P4HTMRAB9ANPC1SMN1; SMN2HDAC2
SCHEMBL7870343 0.88 RAB9A (0.42) P4HTMRAB9ANPC1SMN1; SMN2HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed